{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:04:08Z","timestamp":1790543048794,"version":"4.1.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1111\/j.1567-1364.2006.00121.x","type":"journal-article","created":{"date-parts":[[2006,6,21]],"date-time":"2006-06-21T14:50:07Z","timestamp":1150901407000},"page":"1063-1073","source":"Crossref","is-referenced-by-count":108,"title":["Effect of farnesol on<i>Candida dubliniensis<\/i>biofilm formation and fluconazole resistance"],"prefix":"10.1093","volume":"6","author":[{"given":"Mary Ann","family":"Jabra-Rizk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Shirtliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Meiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB54","doi-asserted-by":"crossref","unstructured":"Baillie GS & Douglas LJ (1999a) Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310: 644\u00e2\u0080\u0093656.","DOI":"10.1016\/S0076-6879(99)10050-8"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB55","doi-asserted-by":"crossref","unstructured":"Baillie GS & Douglas LJ (1999b) Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48: 671\u00e2\u0080\u0093679.","DOI":"10.1099\/00222615-48-7-671"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB20","unstructured":"Baillie GS & Douglas LJ (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46: 397\u00e2\u0080\u0093403."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB51","doi-asserted-by":"crossref","unstructured":"Borg-von Zepelin M , Niederhaus T , Gross U , Seibold M , Monod M & Tintelnot K (2002) Adherence of different Candida dubliniensis isolates in the presence of fluconazole. AIDS 16: 1237\u00e2\u0080\u00931244.","DOI":"10.1097\/00002030-200206140-00005"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB1","doi-asserted-by":"crossref","unstructured":"Brandt ME , Harrison LH , Pass M , Sofair AN , Huie S , Li R-K , Morrison CJ , Warnock DW & Hajjeh RA (2000) Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 6: 1\u00e2\u0080\u00936.","DOI":"10.3201\/eid0601.000108"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB59","doi-asserted-by":"crossref","unstructured":"Brehm-Stecher BF & Johnson EA (2003) Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, apritone. Antimicrob Agents Chemother 47: 3357\u00e2\u0080\u00933360.","DOI":"10.1128\/AAC.47.10.3357-3360.2003"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB49","unstructured":"Brown DM , Jabra-Rizk MA , Falkler WA , Baqui AAMA & Meiller TF (2000) Identification of Candida dubliniensis in a prospective study of HIV-seropositive pediatric dental patients. J Pediatr Dentistry 22: 234\u00e2\u0080\u0093238."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB41","doi-asserted-by":"crossref","unstructured":"Cao YY , Cao YB , Xu Z , Ying K , Li Y , Xie Y , Zhu ZY , Chen WS & Jiang YY (2005) cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 49: 584\u00e2\u0080\u0093589.","DOI":"10.1128\/AAC.49.2.584-589.2005"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB28","doi-asserted-by":"crossref","unstructured":"Chandra J , Kuhn DM , Mulherjee PK , Hoyer LL , McCormick T & Ghannoum MA (2001a) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 5385\u00e2\u0080\u00935394.","DOI":"10.1128\/JB.183.18.5385-5394.2001"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB24","doi-asserted-by":"crossref","unstructured":"Chandra J , Mukherjee PK , Leidich SD , Faddoul FF , Hoyer LL , Douglas LJ & Ghannoum MA (2001b) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80: 903\u00e2\u0080\u0093908.","DOI":"10.1177\/00220345010800031101"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB35","doi-asserted-by":"crossref","unstructured":"Chen H , Fumita M , Feng Q , Clardy J & Fink GR (2004) Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci USA 101: 5048\u00e2\u0080\u00935052.","DOI":"10.1073\/pnas.0401416101"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB39","unstructured":"Davey ME & O'Toole GA (2000) Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64: 847\u00e2\u0080\u0093867."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB21","doi-asserted-by":"crossref","unstructured":"Donlan RM (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8: 1\u00e2\u0080\u009319.","DOI":"10.3201\/eid0809.020063"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB17","unstructured":"Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167\u00e2\u0080\u0093193."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB38","doi-asserted-by":"crossref","unstructured":"Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30\u00e2\u0080\u009336.","DOI":"10.1016\/S0966-842X(02)00002-1"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB58","doi-asserted-by":"crossref","unstructured":"Dumitru R , Hornby JM & Nickerson KW (2004) Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. Antimicrob Agents Chemother 48: 2350\u00e2\u0080\u00932354.","DOI":"10.1128\/AAC.48.7.2350-2354.2004"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB45","unstructured":"Edwards PA & Ericsson J (1999) Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68: 157\u00e2\u0080\u0093185."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB40","unstructured":"Enjalbert B & Whiteway M (2005) Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth. Eukaryotic Cell 4: 1203\u00e2\u0080\u00931210."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB47","unstructured":"Garc\u00c3\u00ada-S\u00c3\u00a1nchez S , Aubert S , Iraqui I , Janbon G , Ghigo J-M & d'Enfert C (2004) Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryotic Cell 3: 536\u00e2\u0080\u0093545."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB36","unstructured":"Hornby JM & Nickerson KW (2004) Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob Agents Chemother 48: 2305\u00e2\u0080\u00932307."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB34","doi-asserted-by":"crossref","unstructured":"Hornby JM , Jensen EC , Lisec AD , Tasto JJ , Jahnke B , Shoemaker R , Dussault P & Nickerson KW (2001) Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 67: 2982\u00e2\u0080\u00932992.","DOI":"10.1128\/AEM.67.7.2982-2992.2001"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB23","doi-asserted-by":"crossref","unstructured":"Hornby JM , Kebaara BW & Nickerson KW (2003) Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zargozic acid B. Antimicrob Agents Chemother 47: 2366\u00e2\u0080\u00932369.","DOI":"10.1128\/AAC.47.7.2366-2369.2003"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB3","doi-asserted-by":"crossref","unstructured":"Jabra-Rizk MA , Baqui AAMA , Kelley JI , Falkler WA Jr , Merz WG & Meiller TF (1999a) Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 37: 321\u00e2\u0080\u0093326.","DOI":"10.1128\/JCM.37.2.321-326.1999"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB61","unstructured":"Jabra-Rizk MA , Falkler WA Jr , Merz WG , Kelley JI , Baqui AAMA & Meiller TF (1999b) Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation. Rev Iberoam Micol 16: 8\u00e2\u0080\u009314."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB10","unstructured":"Jabra-Rizk MA , Falkler WA Jr , Merz WG , Baqui AAMA , Kelley JI & Meiller TF (2000) Retrospective identification of Candida dubliniensis among Candida albicans clinical laboratory isolates from HIV and non-HIV individuals. J Clin Microbiol 38: 2423\u00e2\u0080\u00932426."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB60","unstructured":"Jabra-Rizk MA , Falkler WF Jr , Merz WG , Baqui AAMA , Kelley JI & Meiller TF (2001a) Cell surface hydrophobicity-associated adherence of Candida dubliniensis to human buccal epithelial cells. Rev Iberam Micol 18: 17\u00e2\u0080\u009322."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB62","doi-asserted-by":"crossref","unstructured":"Jabra-Rizk MA , Falkler WA Jr , Merz WG & Meiller TF (2001b) New assay for measuring cell surface hydrophobicity of Candida dubliniensis and Candida albicans. Clin Diagn Lab Immunol 8: 585\u00e2\u0080\u0093587.","DOI":"10.1128\/CDLI.8.3.585-587.2001"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB4","doi-asserted-by":"crossref","unstructured":"Jabra-Rizk MA , Ferreira SMS , Sabet M , Falkler WA , Merz WG & Meiller TF (2001c) Recovery of Candida dubliniensis and other yeast from human immunodeficiency virus-associated periodontal lesions. J Clin Microbiol 39: 4520\u00e2\u0080\u00934522.","DOI":"10.1128\/JCM.39.12.4520-4522.2001"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB29","doi-asserted-by":"crossref","unstructured":"Jabra-Rizk MA , Falkler WA Jr & Meiller TF (2004) Fungal biofilms and drug resistance. Emerg Infect Dis 10: 14\u00e2\u0080\u009319.","DOI":"10.3201\/eid1001.030119"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB9","doi-asserted-by":"crossref","unstructured":"Jabra-Rizk MA , Johnson JK , Forrest G , Mankes K , Meiller TF & Venezia RA (2005) Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin Infect Dis 41: 1064\u00e2\u0080\u00931067.","DOI":"10.1086\/432943"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB2","doi-asserted-by":"crossref","unstructured":"Kim JO , Garofalo L , Blecker-Shelly D & McGowan KL (2003) Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans. J Clin Microbiol 41: 3354\u00e2\u0080\u00933357.","DOI":"10.1128\/JCM.41.7.3354-3357.2003"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB30","doi-asserted-by":"crossref","unstructured":"Kirkpatrick WR , Lopez-Ribot JL , McAtee RK & Patterson TF (2000) Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions. J Clin Microbiol 38: 902\u00e2\u0080\u0093904.","DOI":"10.1128\/JCM.38.2.902-904.2000"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB25","doi-asserted-by":"crossref","unstructured":"Kruppa M , Krom BP , Chauhan N , Bambach AV , Cihlar RL & Calderone RA (2004) The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryotic Cell 3: 1062\u00e2\u0080\u00931065.","DOI":"10.1128\/EC.3.4.1062-1065.2004"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB22","doi-asserted-by":"crossref","unstructured":"Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45: 999\u00e2\u0080\u00931007.","DOI":"10.1128\/AAC.45.4.999-1007.2001"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB46","doi-asserted-by":"crossref","unstructured":"Machida K , Tanaka T , Fujita K & Taniguchi M (1998) Farnesol-induced generation of reactive oxygen species via indirect inhibition of the mitochondrial electron transport chain in the yeast Saccharomyces cerevisiae. J Bacteriol 180: 4460\u00e2\u0080\u00934465.","DOI":"10.1128\/JB.180.17.4460-4465.1998"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB5","unstructured":"Meis JFGM , Ruhnke M , De Pauw BE , Odds FC , Siegert W & Verweij PE (1999) Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 5: 150\u00e2\u0080\u0093153."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB11","doi-asserted-by":"crossref","unstructured":"Moran GP , Sullivan DJ , Henman MC , McCreary CE , Harrington BJ , Shanley DB & Coleman DC (1997) Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41: 617\u00e2\u0080\u0093623.","DOI":"10.1128\/AAC.41.3.617"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB12","doi-asserted-by":"crossref","unstructured":"Moran GP , Sanglard D , Donnelly SM , Shanley D , Sullivan DJ & Coleman DC (1998) Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 42: 1819\u00e2\u0080\u00931830.","DOI":"10.1128\/AAC.42.7.1819"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB52","doi-asserted-by":"crossref","unstructured":"Moran G , Sullivan DJ , Morschhauser J & Coleman DC (2002) The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance. Animicrob Agents Chemother 46: 2829\u00e2\u0080\u00932941.","DOI":"10.1128\/AAC.46.9.2829-2841.2002"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB42","doi-asserted-by":"crossref","unstructured":"Mosel DD , Dumitru R , Hornby JM , Atkin AL & Nickerson KW (2005) Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl Environ Microbiol 71: 4938\u00e2\u0080\u00934940.","DOI":"10.1128\/AEM.71.8.4938-4940.2005"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB48","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard","author":"National Committee for Clinical Laboratory Standards","year":"1997"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB31","unstructured":"Oh K-B , Miyazawa H , Naito T & Matsuoka H (2001) Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans. Proc Natl Acad Sci USA 98: 4664\u00e2\u0080\u00934668."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB18","doi-asserted-by":"crossref","unstructured":"O'Toole GA , Kaplan HB & Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54: 49\u00e2\u0080\u009379.","DOI":"10.1146\/annurev.micro.54.1.49"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB26","unstructured":"Plochocka D , Karst F , Swiezewska E & Szkopinska A (2000) The role of ERG20 gene (encoding yeast farnesyl diphosphate synthase) mutation in long dolichol formation. Molecular modeling of FPP syntase. Biochimie 82: 733\u00e2\u0080\u0093738."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB19","doi-asserted-by":"crossref","unstructured":"Ramage G , Vande Walle K , Wickes BL & L\u00c3\u00b3pez-Ribot JL (2001) Biofilm formation by Candida dubliniensis. J Clin Microbiol 39: 3234\u00e2\u0080\u00933240.","DOI":"10.1128\/JCM.39.9.3234-3240.2001"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB53","doi-asserted-by":"crossref","unstructured":"Ramage G , Bachmann S , Patterson TF , Wickes BL & L\u00c3\u00b3pez-Ribot JL (2002a) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49: 973\u00e2\u0080\u0093980.","DOI":"10.1093\/jac\/dkf049"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB37","doi-asserted-by":"crossref","unstructured":"Ramage G , Saville SP , Wickes BL & L\u00c3\u00b3pez-Ribot JL (2002b) Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 68: 5459\u00e2\u0080\u00935463.","DOI":"10.1128\/AEM.68.11.5459-5463.2002"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB63","doi-asserted-by":"crossref","unstructured":"Ramage G , VandeWalle K , Bachmann S , Wickes BL & L\u00c3\u00b3pez-Ribot JL (2002c) In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46: 3634\u00e2\u0080\u00933636.","DOI":"10.1128\/AAC.46.11.3634-3636.2002"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB27","doi-asserted-by":"crossref","unstructured":"Sato T , Watanabe T , Mikami T & Matsumoto T (2004) Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. Biol Pharmacy Bull 27: 751\u00e2\u0080\u0093752.","DOI":"10.1248\/bpb.27.751"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB32","unstructured":"Saville SP , Lazzell AL , Monteagudo C & L\u00c3\u00b3pez-Ribot JL (2002) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryotic Cell 2: 1053\u00e2\u0080\u00931060."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB6","doi-asserted-by":"crossref","unstructured":"Sebti A , Kiehn TE , Perlin D , Chaturvedi V , Wong M , Doney A , Park S & Sepkowitz KA (2001) Candida dubliniensis at a cancer center. Clin Infect Dis 32: 1034\u00e2\u0080\u00931038.","DOI":"10.1086\/319599"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB56","unstructured":"Shchepin R , Hornby JM , Burger E , Niessen T , Dussault P & Nickerson KW (2003) Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chem Biol 10: 743\u00e2\u0080\u0093750."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB57","doi-asserted-by":"crossref","unstructured":"Shchepin R , Dumitru R , Nickerson KW , Lund M & Dussault PH (2005) Biologically active fluorescent farnesol analogs. Chem Biol 12: 639\u00e2\u0080\u0093641.","DOI":"10.1016\/j.chembiol.2005.04.008"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB44","doi-asserted-by":"crossref","unstructured":"Song L (2003) Detection of farnesyl diphosphate accumulation in yeast ERG9 mutants. Anal Biochem 317: 180\u00e2\u0080\u0093185.","DOI":"10.1016\/S0003-2697(03)00138-6"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB33","doi-asserted-by":"crossref","unstructured":"Staib P , Kretschmar M , Nichterlein T , Kohler G , Michel S , Hof H , Hacker J & Morschhauser J (1999) Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol 32: 533\u00e2\u0080\u0093546.","DOI":"10.1046\/j.1365-2958.1999.01367.x"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB8","unstructured":"Sullivan D & Coleman D (1997) Candida dubliniensis an emerging opportunistic pathogen. Curr Top Med Mycol 8: 15\u00e2\u0080\u009325."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB50","unstructured":"Sullivan D , Westerneng T , Haynes KA , Bennett D & Coleman D (1995) Candida dubliniensis sp. nov.=phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology 141: 1507\u00e2\u0080\u00931521."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB7","doi-asserted-by":"crossref","unstructured":"Sullivan D , Haynes K , Bille J , Boerlin P , Rodero L , Lloyd S , Henman M & Coleman D (1997) Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 35: 960\u00e2\u0080\u0093964.","DOI":"10.1128\/JCM.35.4.960-964.1997"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB13","unstructured":"Sullivan DJ , Moran GP , Pinjon E , Al-Mosaid A , Stokes C , Vaughan C & Coleman DC (2004) Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 4: 369\u00e2\u0080\u0093376."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB43","unstructured":"Szkopi\u00c5\u0084ska A , Grabi\u00c5\u0084ska K , Delourme D , Karst F , Rytka J & Palamarczyk G (1997) Polyprenol formation in the yeast Saccharomyces cerevisiae: effect of farnesyl diphosphate synthase overexpression. J Lipid Res 38: 962\u00e2\u0080\u0093968."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB14","unstructured":"White TC (1997) Increased mRNA levels of ERG 16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 1482\u00e2\u0080\u00931487."},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB15","doi-asserted-by":"crossref","unstructured":"White TC , Marr KA & Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11: 382\u00e2\u0080\u0093402.","DOI":"10.1128\/CMR.11.2.382"},{"key":"10.1111\/j.1567-1364.2006.00121.x-BIB16","doi-asserted-by":"crossref","unstructured":"White TC , Holleman S , Dy F , Mirels LF & Stevens DA (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46: 1704\u00e2\u0080\u00931713.","DOI":"10.1128\/AAC.46.6.1704-1713.2002"}],"container-title":["FEMS Yeast Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsyr\/article-pdf\/6\/7\/1063\/18017279\/6-7-1063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:39:32Z","timestamp":1586972372000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsyr\/article-lookup\/doi\/10.1111\/j.1567-1364.2006.00121.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1567-1364.2006.00121.x","relation":{},"ISSN":["1567-1356","1567-1364"],"issn-type":[{"value":"1567-1356","type":"print"},{"value":"1567-1364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}